Komipharm International

041960 · KOSDAQ · Health Care · SMALL CAP

Updated contract terms.

Komipharm International updated a previously disclosed supply contract with the Public Procurement Service, now worth US$6.82M, about 25.33% of its recent annual revenue, running through Nov 2027.

Supply contract([Amended] Supply contract signed)· FILED 2026-04-08· RCEPT 20260408901068

US$6.82MContract value
25.33%vs. recent revenue
Nov 2027Throughfrom Jan 2024

Converted at 1 USD ≈ ₩1,477.6 (filing-date rate, 2026-04-08 close)

What happened

Komipharm International updated a previously disclosed supply contract with the Public Procurement Service, now worth US$6.82M, about 25.33% of its recent annual revenue, running through Nov 2027.

For context, this single contract equals about 25.33% of the company's most recent annual revenue.

Counterpartythe Public Procurement Service
Contract valueUS$6.82M
vs. recent revenue25.33%
ThroughNov 2027 (from Jan 2024)
Filed2026-04-08, [Amended] Supply contract signed
SourceDART rcept 20260408901068 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-04-08 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.